- Home
- App Analytics
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. SurvivorNet
Multiple Myeloma Management vs SurvivorNet Uso e estatísticas
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
- Apple App Store
- Gratuitos
- Saúde e fitness
Ranking da Loja
- -
Multiple Myeloma Management versus SurvivorNet comparação de classificação
Compare a tendência de classificação de Multiple Myeloma Management nos últimos 28 dias versus SurvivorNet
Classificação
Nenhum dado disponível
Comparação da classificação de Multiple Myeloma Management vs. SurvivorNet por país
Compare a tendência de classificação de Multiple Myeloma Management nos últimos 28 dias versus SurvivorNet
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
Multiple Myeloma Management VS.
SurvivorNet
19ezembro d, 2024